Skip to content
HowShorted

ANAVEX LIFE SCIENCES CORP. short interest in 2024

In 2024, ANAVEX LIFE SCIENCES CORP.'s disclosed short interest ran from 25.16% of shares outstanding on 12 Jan 2024 to 25.70% on 31 Dec 2024, a change of +0.54 percentage points. The year's high was 26.94% on 28 Mar 2024 and its low 20.75% on 30 Sep 2024, averaging 23.89% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 36.82 days on 15 Oct 2024. Full history: ANAVEX LIFE SCIENCES CORP..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ANAVEX LIFE SCIENCES CORP. in 2024

2024 in figures

Start of year
25.16% (12 Jan 2024)
End of year
25.70% (31 Dec 2024)
Change
+0.54 pp
High
26.94% (28 Mar 2024)
Low
20.75% (30 Sep 2024)
Average
23.89%
Highest days to cover
36.82 (15 Oct 2024)
SEC filings marked
5

Every report in 2024

ANAVEX LIFE SCIENCES CORP. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 202425.16%7.57
31 Jan 202424.52%20.66
15 Feb 202424.23%17.0910-Q filed
29 Feb 202424.39%15.62
15 Mar 202424.36%12.15
28 Mar 202426.94%18.17
15 Apr 202426.81%19.96
30 Apr 202425.94%15.60
15 May 202425.83%21.2310-Q filed, results (8-K)
31 May 202425.77%21.10
14 Jun 202424.74%19.54
28 Jun 202421.06%10.53
15 Jul 202421.79%22.97
31 Jul 202423.49%13.08
15 Aug 202423.29%21.3610-Q filed
30 Aug 202422.86%33.23
13 Sep 202423.12%25.74
30 Sep 202420.75%22.94
15 Oct 202421.12%36.82
31 Oct 202421.59%18.52
15 Nov 202422.18%10.06
29 Nov 202423.22%12.43
13 Dec 202424.55%16.40
31 Dec 202425.70%7.3210-K filed

See also: ANAVEX LIFE SCIENCES CORP.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.